ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription Drug User Fee Act - implementation and general legislative planning
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE BLOOMQUIST | — |
| BRANTLEY CARLSON | — |
| MARIA FIRVIDA | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
| JOHN MYERS | — |
| LAURA OKPALA | — |
Medicare/Medicaid MMM
Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and remimbursement Medicaid Coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE BLOOMQUIST | — |
| BRANTLEY CARLSON | — |
| MARIA FIRVIDA | — |
| JULIE GARNER | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
| JOHN MYERS | — |
| LAURA OKPALA | — |
Health Issues HCR
American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE BLOOMQUIST | — |
| BRANTLEY CARLSON | — |
| MARIA FIRVIDA | — |
| JULIE GARNER | — |
| THERESA JOLIVETTE | — |
| NATALIE MORRIS | — |
| JOHN MYERS | — |
| LAURA OKPALA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.